924900-99-2

Upstream product

• 151058-19-4 (S)-4-Benzyl-3-[(2S,3R,4R)-5-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2,4-dimethyl-pentanoyl]-oxazolidin-2-one 
• 924900-96-9 C₁₃H₃₀O₃Si 
• 924900-98-1 C₂₁H₃₆O₄Si 

Downstream Products

• 924900-97-0 (3S,4S,5R,7R,8S,9S)-6-(4-methoxybenzyloxy)-3,5,7,9-tetramethyl-1,10-undecadiene-4,8-diol 
• 924901-00-8 C₂₃H₃₄O₄ 
• 924901-01-9 C₂₄H₃₆O₆S 
• 924901-04-2 C₂₃H₃₄O₃ 
• 1027016-57-4 C₃₂H₅₄O₄Si 
• 1026707-16-3 C₃₂H₅₆O₆Si 

Relevant academic research and scientific papers

Studies toward the total synthesis of irumamycin: stereoselective preparation of the C(15)-C(27) segment via two-directional chain synthesis

The basic structure of the C(15)-C(27) part of irumamycin (1) was synthesized. Stereoselective assembly of C16, 17, 22, and an extra C21 stereocenter was achieved by two-directional Brown's asymmetric allyl boration. Group selective PMP acetal formation and oxidative cleavage of vinyl group facilitated the differentiation of the ends of a two-directionally synthesized chain.